Ruby Bio

Oakland, United States

Ruby Bio is a biosynthesis platform that manufactures biodegradable and non-toxic molecules.

$8.0M raised

Jun 2025

Venture - Series Unknown

Top Investors

Alumni VenturesThe Venture CollectiveKicker Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Ruby Bio raised?

Ruby Bio has raised $8.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2025.

Who are Ruby Bio's investors?

Ruby Bio's investors include Alumni Ventures, The Venture Collective, Kicker Ventures.

Where is Ruby Bio headquartered?

Ruby Bio is headquartered in Oakland, United States.

What does Ruby Bio do?

Ruby Bio is a biosynthesis platform that manufactures biodegradable and non-toxic molecules.

What stage is Ruby Bio at?

Ruby Bio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 9, 2025.

MLA

"Ruby Bio — Funding & Investors." VCBacked, June 9, 2025, https://www.vcbacked.co/company/ruby-bio. Accessed June 8, 2026.

APA

VCBacked. (2025). Ruby Bio — Funding & Investors. Retrieved June 8, 2026, from https://www.vcbacked.co/company/ruby-bio

Wikipedia (cite web)

{{cite web |title=Ruby Bio — Funding & Investors |url=https://www.vcbacked.co/company/ruby-bio |website=VCBacked |access-date=June 8, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 9, 2025.